{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:38:38Z","timestamp":1771267118280,"version":"3.50.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p\/>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>The ISCHEMIA trial is a landmark study that has been the subject of heated debate within the cardiovascular community. In this analysis of the ISCHEMIA trial, we aim to set the record straight on the benefits of coronary artery bypass grafting (CABG) and the misinterpretation of this landmark trial. We sought to clarify and reorient this misinterpretation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We herein analyse the ISCHEMIA trial in detail and describe how its misinterpretation has led to an erroneous guideline recommendation downgrading for prognosis-altering surgical therapy in these at-risk patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The interim ISCHEMIA trial findings align with previous evidence where CABG reduces the long-term risks of myocardial infarction and mortality in advanced coronary artery disease. The trial outcomes of a significantly lower rate of cardiovascular mortality and a higher rate of non-cardiovascular mortality with the invasive strategy are explained according to landmark evidence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The ISCHEMIA trial findings are aligned with previous evidence and should not be used to downgrade recommendations in recent guidelines for the indisputable benefits of CABG.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezad361","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T20:54:49Z","timestamp":1698353689000},"source":"Crossref","is-referenced-by-count":5,"title":["The ISCHEMIA trial revisited: setting the record straight on the benefits of coronary bypass surgery and the misinterpretation of a landmark trial"],"prefix":"10.1093","volume":"64","author":[{"given":"Walter J","family":"Gomes","sequence":"first","affiliation":[{"name":"Cardiovascular Surgery Discipline, Escola Paulista de Medicina and S\u00e3o Paulo Hospital, Federal University of S\u00e3o Paulo , S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-4710","authenticated-orcid":false,"given":"Mateo","family":"Marin-Cuartas","sequence":"additional","affiliation":[{"name":"University Department of Cardiac Surgery, Leipzig Heart Center , Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Bakaeen","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Heart, Vascular and Thoracic Institute, Cleveland Clinic , Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Rafael","family":"S\u00e1daba","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, University Hospital of Navarra , Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-0585","authenticated-orcid":false,"given":"Victor","family":"Dayan","sequence":"additional","affiliation":[{"name":"Centro Cardiovascular Universitario , Montevideo, Uruguay"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-3367","authenticated-orcid":false,"given":"Rui","family":"Almeida","sequence":"additional","affiliation":[{"name":"University Center Assis Gurgacz Foundation , Cascavel, Paran\u00e1, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Parolari","sequence":"additional","affiliation":[{"name":"Unit of Cardiac Surgery, IRCCS Policlinico S. Donato, University of Milan , S. Donato Milanese, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1768-8433","authenticated-orcid":false,"given":"Patrick O","family":"Myers","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, CHUV\u2014Lausanne University Hospital , Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1046-1364","authenticated-orcid":false,"given":"Michael A","family":"Borger","sequence":"additional","affiliation":[{"name":"University Department of Cardiac Surgery, Leipzig Heart Center , Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"2023110721573922500_ezad361-B1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2023110721573922500_ezad361-B2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.123.065190","article-title":"Survival after invasive or conservative management of stable coronary disease","volume":"148","author":"Solomon","year":"2023","journal-title":"Circulation"},{"key":"2023110721573922500_ezad361-B3","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023110721573922500_ezad361-B4","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.athoracsur.2021.06.039","article-title":"Sex differences in coronary artery bypass grafting techniques: a Society of Thoracic Surgeons Database analysis","volume":"113","author":"Jawitz","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"2023110721573922500_ezad361-B5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.120.049755","article-title":"Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity","volume":"144","author":"Reynolds","year":"2021","journal-title":"Circulation"},{"key":"2023110721573922500_ezad361-B6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ahj.2012.05.018","article-title":"Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention","volume":"164","author":"Shaw","year":"2012","journal-title":"Am Heart J"},{"key":"2023110721573922500_ezad361-B7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcin.2013.10.017","article-title":"Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia","volume":"7","author":"Mancini","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2023110721573922500_ezad361-B8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCULATIONAHA.121.054102","article-title":"Forget ischemia: it's all about the plaque","volume":"144","author":"Newby","year":"2021","journal-title":"Circulation"},{"key":"2023110721573922500_ezad361-B9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"2023110721573922500_ezad361-B10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/CIRCULATIONAHA.106.625475","article-title":"Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"115","author":"Hueb","year":"2007","journal-title":"Circulation"},{"key":"2023110721573922500_ezad361-B11","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"2023110721573922500_ezad361-B12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"2023110721573922500_ezad361-B13","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1093\/eurheartj\/ehu213","article-title":"Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial","volume":"35","author":"Head","year":"2014","journal-title":"Eur Heart J"},{"key":"2023110721573922500_ezad361-B14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jchf.2019.04.018","article-title":"CABG improves outcomes in patients with ischemic cardiomyopathy: 10-year follow-up of the STICH Trial","volume":"7","author":"Howlett","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2023110721573922500_ezad361-B15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2018.11.001","article-title":"Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study","volume":"73","author":"Farkouh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023110721573922500_ezad361-B16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2016.06.021","article-title":"Medical treatment and revascularization options in patients with type 2 diabetes and coronary disease","volume":"68","author":"Mancini","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2023110721573922500_ezad361-B17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2022.01.017","article-title":"Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial","volume":"248","author":"Sidhu","year":"2022","journal-title":"Am Heart J"},{"key":"2023110721573922500_ezad361-B18","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa1505532","article-title":"Effect of PCI on long-term survival in patients with stable ischemic heart disease","volume":"373","author":"Sedlis","year":"2015","journal-title":"N Engl J Med"},{"key":"2023110721573922500_ezad361-B19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jacc.2015.10.043","article-title":"Causes of death following PCI versus CABG in complex CAD: 5-year follow-up of SYNTAX","volume":"67","author":"Milojevic","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2023110721573922500_ezad361-B20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(19)31997-X","article-title":"Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial","volume":"394","author":"Thuijs","year":"2019","journal-title":"Lancet"},{"key":"2023110721573922500_ezad361-B21","doi-asserted-by":"crossref","first-page":"oeac012","DOI":"10.1093\/ehjopen\/oeac012","article-title":"Is non-cardiac death increased with an initial invasive revascularization strategy? Commentary on the ISCHEMIA trial","volume":"2","author":"Rodriguez","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2023110721573922500_ezad361-B22","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1056\/NEJMoa1909406","article-title":"Five-year outcomes after PCI or CABG for left main coronary disease","volume":"381","author":"Stone","year":"2019","journal-title":"N Engl J Med"},{"key":"2023110721573922500_ezad361-B23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ejcts\/ezaa121","article-title":"The transfiguration of the EXCEL trial: exceeding ethical and moral boundaries","volume":"58","author":"Gomes","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"2023110721573922500_ezad361-B24","doi-asserted-by":"crossref","first-page":"I","DOI":"10.21470\/1678-9741-1-2020-0609","article-title":"New revelations ignite the EXCEL affair and expose the distortion of science","volume":"35","author":"Gomes","year":"2020","journal-title":"Braz J Cardiovasc Surg"},{"key":"2023110721573922500_ezad361-B25","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa1415447","article-title":"Trial of everolimus-eluting stents or bypass surgery for coronary disease","volume":"372","author":"Park","year":"2015","journal-title":"N Engl J Med"},{"key":"2023110721573922500_ezad361-B26","author":"Werner","year":"2019"},{"key":"2023110721573922500_ezad361-B27","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1093\/eurheartj\/ehx512","article-title":"Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study","volume":"38","author":"Escaned","year":"2017","journal-title":"Eur Heart J"},{"key":"2023110721573922500_ezad361-B28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(18)31715-X","article-title":"Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial","volume":"392","author":"Pilgrim","year":"2018","journal-title":"Lancet"},{"key":"2023110721573922500_ezad361-B29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.amjcard.2020.12.076","article-title":"Comparison of outcomes of percutaneous coronary intervention versus coronary artery bypass grafting among patients with three-vessel coronary artery disease in the new-generation drug-eluting stents era (From CREDO-Kyoto PCI\/CABG Registry Cohort-3)","volume":"145","author":"Matsumura-Nakano","year":"2021","journal-title":"Am J Cardiol"},{"key":"2023110721573922500_ezad361-B30","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1001\/jamainternmed.2020.4748","article-title":"Overall and cause-specific mortality in randomized clinical trials comparing percutaneous interventions with coronary bypass surgery: a meta-analysis","volume":"180","author":"Gaudino","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2023110721573922500_ezad361-B31","doi-asserted-by":"crossref","first-page":"e000405","DOI":"10.1136\/openhrt-2016-000405","article-title":"Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI","volume":"3","author":"Doost Hosseiny","year":"2016","journal-title":"Open Heart"},{"key":"2023110721573922500_ezad361-B32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.113.006518","article-title":"Trends in cause of death after percutaneous coronary intervention","volume":"129","author":"Spoon","year":"2014","journal-title":"Circulation"},{"key":"2023110721573922500_ezad361-B33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa2112299","article-title":"Fractional flow reserve-guided PCI as compared with coronary bypass surgery","volume":"386","author":"Fearon","year":"2022","journal-title":"N Engl J Med"},{"key":"2023110721573922500_ezad361-B34","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"2023110721573922500_ezad361-B35","first-page":"134","article-title":"Persistent inflammatory activity in blood cells and artery tissue from patients with previous bare metal stent","volume":"111","author":"Farsky","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"2023110721573922500_ezad361-B36","doi-asserted-by":"crossref","first-page":"e007244","DOI":"10.1161\/JAHA.117.007244","article-title":"Very Late pathological responses to cobalt-chromium everolimuseluting, stainless steel sirolimus-eluting, and cobalt-chromium bare metal stents in humans","volume":"6","author":"Mori","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2023110721573922500_ezad361-B37","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.athoracsur.2005.10.014","article-title":"Coronary stenting and inflammation: implications for further surgical and medical treatment","volume":"81","author":"Gomes","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2023110721573922500_ezad361-B38","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"2023110721573922500_ezad361-B39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappa B in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"2023110721573922500_ezad361-B40","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3390\/ijms18081808","article-title":"Crosstalk between DNA damage and inflammation in the multiple steps of carcinogenesis","volume":"18","author":"Kawanishi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2023110721573922500_ezad361-B41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mad.2008.06.003","article-title":"Inflammation, ageing and cancer","volume":"130","author":"Vasto","year":"2009","journal-title":"Mech Ageing Dev"},{"key":"2023110721573922500_ezad361-B42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pcad.2020.02.009","article-title":"Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: learning from pathophysiology to optimize treatment","volume":"63","author":"Mangiacapra","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"2023110721573922500_ezad361-B43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2019.03.016","article-title":"Neoatherosclerosis\u2014from basic concept to clinical implication","volume":"178","author":"Mazin","year":"2019","journal-title":"Thromb Res"},{"key":"2023110721573922500_ezad361-B44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.athoracsur.2023.02.007","article-title":"STS\/AATS-endorsed Rebuttal to 2023 ACC\/AHA chronic coronary disease guideline: a missed opportunity to present accurate and comprehensive revascularization recommendations","volume":"116","author":"Bakaeen","year":"2023","journal-title":"Ann Thorac Surg"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezad361\/52632305\/ezad361.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/64\/5\/ezad361\/52799565\/ezad361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/64\/5\/ezad361\/52799565\/ezad361.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T22:38:29Z","timestamp":1699396709000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezad361\/7331035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezad361","relation":{},"ISSN":["1873-734X"],"issn-type":[{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2023,10,27]]},"article-number":"ezad361"}}